iShares U.S. Pharmaceuticals ETF (IHE) Holdings $63.60 +0.11 (+0.17%) As of 05/23/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Top 41 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1JNJJohnson & Johnson$153.12+0.3%23.64%866,5502LLYEli Lilly and Company$713.99-0.2%22.78%171,7043ZTSZoetis$162.92+0.6%5.07%174,5654RPRXRoyalty Pharma$32.45+0.4%5.05%859,1665VTRSViatris$8.29-2.5%4.82%3,054,4956PFEPfizer$23.33+1.3%4.58%1,097,7697MRKMerck & Co., Inc.$77.59-0.3%4.19%302,3388BMYBristol-Myers Squibb$46.88-0.3%4.01%471,8839CORTCorcept Therapeutics$78.69+3.4%3.27%241,92710JAZZJazz Pharmaceuticals$108.07+0.2%3.09%156,839 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11ELANElanco Animal Health$12.66-0.1%2.98%1,282,53712AXSMAxsome Therapeutics$105.07+0.7%2.03%105,61813PBHPrestige Consumer Healthcare$85.98+1.1%2.00%128,51814PRGOPerrigo$26.52+0.5%1.72%353,94315OGNOrganon & Co.$8.691.04%668,15016LGNDLigand Pharmaceuticals$101.60+0.3%0.91%49,02417SUPNSupernus Pharmaceuticals$32.10+0.2%0.84%143,25918TARSTarsus Pharmaceuticals$42.98+0.0%0.72%90,24619HRMYHarmony Biosciences$34.17+0.1%0.63%99,13320PCRXPacira BioSciences$25.75-1.2%0.57%119,79321AMRXAmneal Pharmaceuticals$7.16-0.4%0.51%385,85022INVAInnoviva$18.97+0.8%0.48%142,93523EWTXEdgewise Therapeutics$14.21+1.4%0.47%179,23824ANIPANI Pharmaceuticals$57.79+0.9%0.46%43,05625COLLCollegium Pharmaceutical$28.86+0.1%0.45%83,68126OCULOcular Therapeutix$7.30+1.1%0.45%330,53027AMPHAmphastar Pharmaceuticals$24.47+1.1%0.43%97,30628HROWHarrow$25.90+0.6%0.40%79,52629LQDALiquidia$15.35-1.3%0.37%123,13030WVEWave Life Sciences$5.95-2.3%0.35%304,93631NUVBNuvation Bio$2.31+2.7%0.25%660,13132ELVNEnliven Therapeutics$16.40-2.2%0.24%78,71133EOLSEvolus$9.68+1.3%0.23%127,86234MNMDMind Medicine (MindMed)$7.30+3.3%0.23%170,85335ARVNArvinas$6.51+0.6%0.20%165,58636USDProShares Ultra Semiconductors$52.20-2.4%0.16%910,24237TBPHTheravance Biopharma$9.30-2.0%0.15%90,35238BLK CSH FND TREASURY SL AGENCYN/A0.11%638,61639OMEROmeros$3.16-1.9%0.09%150,01840CASH COLLATERAL USD SGAFTN/A0.02%116,000The Hidden Energy Source Backed by Billionaires (Ad) Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah Mountains in Utah. Bezos, Buffett, and Gates are getting involved. But few Americans know why this remote patch of land is suddenly worth billions. One of our own insiders even filed a FOIA request in Washington to get to get the truth.Click here to see what he uncovered (and why it could make you rich).41E-MINI HEALTH CARE SECTOR JUN 25N/A0.00%12 Geographic ExposureUnited States94.6%Ireland4.8%Singapore0.3%Cayman Islands0.2%Currency ExposureUSD100.0%Sector ExposureHealth Care99.3%Energy0.5%Industry ExposureBiotechnology82.7%Pharmaceuticals16.2%Renewable Energy0.5%Health Care Equipment & Supplies0.4%SubIndustry ExposureBiotechnology79.0%Pharmaceuticals18.4%Renewable Energy Equipment0.5%Health Care Supplies0.4%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies Direxion Daily S&P Biotech Bull 3x Shares Portfolio VanEck Pharmaceutical ETF Portfolio iShares U.S. Healthcare Providers ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio VanEck Biotech ETF Portfolio Invesco Pharmaceuticals ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio First Trust Health Care AlphaDEX Fund Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NYSEARCA:IHE) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.